Teva Pharmaceutical reported 2.06B in Cash and Equivalent for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Aspen Pharmacare APN:SJ 787.6B 779.05B
Jiangsu Hengrui Me. 600276:CH CH 541.54M 13.06B
Kalbe Farma Tbk Pt KLBF:IJ RI 2062460.41M 1317107.52M
Richter Gedeon RICHT:HB 59.76B 14.27B
Sh Fosun Pharma 600196:CH CH 11.44B 293.33M
Teva Pharmaceutical TEVA:IT 2.06B 117M